Abstract:Inflammasomes are important sentinels of innate immune defense; they sense pathogens and induce the cell death of infected cells, playing key roles in inflammation, development, and cancer. Several inflammasome sensors detect and respond to specific pathogen- and damage-associated molecular patterns (PAMPs and DAMPs, respectively) by forming a multiprotein complex with the adapters ASC and caspase-1. During disease, cells are exposed to several PAMPs and DAMPs, leading to the concerted activation of multiple inflammasomes. However, the molecular mechanisms that integrate multiple inflammasome sensors to facilitate optimal host defense remain unknown. Here, we discovered that simultaneous inflammasome activation by multiple ligands triggered multiple types of programmed inflammatory cell death, and these effects could not be mimicked by treatment with a pure ligand of any single inflammasome. Furthermore, NLRP3, AIM2, NLRC4, and Pyrin were determined to be members of a large multiprotein complex, along with ASC, caspase-1, caspase-8, and RIPK3, and this complex drove PANoptosis. Furthermore, this multiprotein complex was released into the extracellular space and retained as multiple inflammasomes. Multiple extracellular inflammasome particles could induce inflammation after their engulfment by neighboring macrophages. Collectively, our findings define a previously unknown regulatory connection and molecular interaction between inflammasome sensors, which drives the assembly of a multiprotein complex that includes multiple inflammasome sensors and cell death regulators. The discovery of critical interactions among NLRP3, AIM2, NLRC4, and Pyrin represents a new paradigm in understanding the functions of these molecules in innate immunity and inflammasome biology as well as identifying new therapeutic targets for NLRP3-, AIM2-, NLRC4- and Pyrin-mediated diseases.

Consecutive palmitoylation and phosphorylation orchestrates NLRP3 membrane trafficking and inflammasome activation

Phosphodiesterase 4B is Required for NLRP3 Inflammasome Activation by Positive Feedback with Nrf2 in the Early Phase of LPS- Induced Acute Lung Injury

ZDHHC5-mediated NLRP3 Palmitoylation Promotes NLRP3-NEK7 Interaction and Inflammasome Activation.

Palmitoylation prevents sustained inflammation by limiting NLRP3 inflammasome activation through chaperone-mediated autophagy

NLRP3 phosphorylation in its LRR domain critically regulates inflammasome assembly

NLRP3 cages revealed by full-length mouse NLRP3 structure control pathway activation

Regulation of NLRP3 Inflammasome by Phosphorylation

NLRP3 Cys126 palmitoylation by ZDHHC7 promotes inflammasome activation

Palmitoylation of NLRP3 Modulates Inflammasome Activation and Inflammatory Bowel Disease Development.

NLRP3 Phosphorylation is an Essential Priming Event for Inflammasome Activation.

Palmitoylation promotes chaperone-mediated autophagic degradation of NLRP3 to modulate inflammation

NLRP3 inflammasome assembly is regulated by phosphorylation of the pyrin domain

Acetylation is required for NLRP3 self-aggregation and full activation of the inflammasome

Distinct changes in endosomal composition promote NLRP3 inflammasome activation

How location and cellular signaling combine to activate the NLRP3 inflammasome

Integrated NLRP3, AIM2, NLRC4, Pyrin inflammasome activation and assembly drive PANoptosis

Structural basis for the oligomerization-facilitated NLRP3 activation

Disruptions in endocytic traffic contribute to the activation of the NLRP3 inflammasome

Defective Endosome-Tgn Retrograde Transport Promotes NLRP3 Inflammasome Activation

PtdIns4P on dispersed trans-Golgi network mediates NLRP3 inflammasome activation

Recent Insights into the Regulatory Networks of NLRP3 Inflammasome Activation